|
1) Moore B. A soluble protein characteristics of the nervous system. Biochem Biophys Res Commun. 1965; 585: 335-9
|
|
|
|
|
2) Isobe T, Ishioka N, Masuda T, et al. A rapid separation of S100 subunits by high performance liquid chromatography; the subunit compositions of S100 proteins. Biochem Int. 1983; 6: 419-26
|
|
|
|
|
3) Schafer BW, Wicki R, Engelkamp D, et al. Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics. 1995; 25: 638-43
|
|
|
|
|
4) Santamaria-Kieiel L, Rintala-Dempsey AC, Shaw GS. Calcium- dependent and -independent interactions of the S100 protein family. Biochem J. 2006; 396: 201-14
|
|
|
|
|
|
5) Haimoto H, Hosoda S, Kato K. Differential distribution of immmunoreactive S100-alpha and S100-beta proteins in normal non-nervous human tissues. Lab Invest. 1987; 57: 489-98
|
|
|
|
|
|
6) Towned W, Dibble C, Abid K, et al. Rapid elimination of protein S-100B from serum after minor head injury. J Neurotrauma. 2006; 23: 149-55
|
|
|
|
|
|
7) Steiner J, Bernstein HG, Bielau H, et al. Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci. 2007; 8: 2
|
|
|
|
|
|
8) Wiesmann M, Missler U, Gottmann D, et al. Plasma S-100b protein concentration in healthy adults age- and sex-independent. Clin Chem. 1998; 44: 1056-8
|
|
|
|
|
|
9) Portela LVC, Tort ABL, Schaf DV, et al. The serum S100B concentration is age dependent. Clin Chem. 2002; 48: 950-2
|
|
|
|
|
|
10) Hayakata T, Shiozaki T, Tasaki O, et al. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock. 2004; 22: 102-7
|
|
|
|
|
|
11) Gazzolo D, Grutzfeld D, Michetti F, et al. Increased S100B in cerebrospinal fluid of infants with bacterial meningitis: Relationship to brain damage and routine cerebrospinal fluid findings. Clin Chem. 2004; 50: 941-4
|
|
|
|
|
|
12) Pleines UE, Morganti-Kossmann MC, Rancan M, et al. S100β reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma. 2001; 18: 491-8
|
|
|
|
|
|
13) Shore PM, Berger RP, Varma S, et al. Cerebrospinal fluid biomarker versus Glasgow coma scale and Glasgow outcome scale in pediatric traumatic brain injury: The role of young age and inflicted injury. J Neurotrauma. 2007; 24: 75-86
|
|
|
|
|
|
14) Nygaard O, Langbakk B, Romner B. Age-and sex-related change of S-100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurological disorder. Clin Chem. 1997; 43: 541-3
|
|
|
|
|
|
15) Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol. 2001; 33: 637-68
|
|
|
|
|
|
16) Baudier J, Delphin C, Grunwald D, et al. Characterization of the tumor suppressor protein p52 as a protein kinase C substrate and an S100β binding protein. Proc Natl Acad Sci U S A. 1992; 89: 11627-31
|
|
|
|
|
|
17) Stanley LC, Mark RE, Woody RC, et al. Glial cytokines as neuropathogenic factors HIV infection: pathogenic similarities to Alzheimer's disease. J Neuropahol Expt Neurol. 1994; 53: 231-8
|
|
|
|
|
|
18) Michetti F, Massaro A, Russo G, et al. The S-100 antigen in cerebrospinal fluid as possible index of cell injury in the nervous system. J Neurol Sci. 1980; 44: 259-63
|
|
|
|
|
|
19) Sindic C, Chalon M, Cambiaso C, et al. Assessment of damage to the central nervous system by determination of S-100 protein in the cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1982; 45: 1130-5
|
|
|
|
|
|
20) Persson L, Hardemark H-G, Gustafsson J, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous system. Stroke. 1987; 18: 911-8
|
|
|
|
|
|
21) Ingebrigtsen T, Waterloo K, Jacobsen EA, et al. Traumatic brain damage in minor head injury: Relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehabioral outcome. Neurosurgery. 1999; 45: 468-76
|
|
|
|
|
|
22) Raabe A, Grolms C, Keller M, et al. Serum S-100B protein in severe head injury. Neurosurgery. 1999; 45: 477-83
|
|
|
|
|
|
23) Lomas J-P, Dunning J. S-100b protein levels as a predictor for long-term disability after head injury. Emerg Med J. 2005; 22: 889-91
|
|
|
|
|
|
24) Berger RP, Kochanek PM. Urinary S100B concentrations are increased after brain injury in children: A preliminary study. Pediatr Crit Care Med. 2006; 7: 557-61
|
|
|
|
|
|
25) Herrmann M, Jost S, Kutz S, et al. Temporal profile of release of neurobiochemicla markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated on cranial computerized tomography. J Neurotrauma. 2000; 17: 113-22
|
|
|
|
|
|
26) Willoughby KA, Kleindienst A, Mueller C, et al. S100B protein is released by in vitro trauma and reduces delayed neuronal injury. J Neurochem. 2004; 91: 1284-91
|
|
|
|
|
|
27) Kleindienst A, Tolias CM, Corwin FD, et al. Assessment of cerebral S100B levels by proton magnetic resonance spectroscopy after lateral-fluid percussion injury in the rat. J Neurosurg. 2005; 102: 1115-21
|
|
|
|
|
|
28) Townend WJ, Guy MJ, Pani MA, et al. Head injury outcome prediction in the emergency department: a role for protection S-100B？ J Neurol Neurosurg Psychiatry. 2002; 73: 542-6
|
|
|
|
|
|
29) Stranjalis G, Korfias S, Papapetrou C, et al. Elevated serum S-100B protein as a predictor of failure to short-term return to work or activities after mild head injury. J Neurotrauma. 2004; 21: 1070-5
|
|
|
|
|
|
30) Hermann M, Curio N, Jost S, et al. Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. J Neurol Neurosurgery Psychiatry. 2001; 70: 95-100
|
|
|
|
|
|
31) Dimopoulou I, KorfiasS, Dafni U, et al. Protein S-100b serum levels in trauma-induced brain death. Neurology. 2003; 60: 947-50
|
|
|
|
|
|
32) Ingebrigtsen T, Romer B, Marup-Jensen S, et al. The clinical value of serum S-100 protein measurements in minor head injury: a Scandianavian multicentre study. Brain Inj. 2000; 14: 1047-55
|
|
|
|
|
|
33) Romner B, Ingebrigtsen T, Kongstad P, et al. Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings. J Neurotrauma. 2000; 17: 641-7
|
|
|
|
|
|
34) Biberthaler P, Mussack T, Wiedemann E, et al. Evaluation of S-100b as a specific marker for neuronal damage due to minor head trauma. World J Surg. 2001; 25: 93-7
|
|
|
|
|
|
35) Mussack T, Biberthaler P, Kanz KG, et al. Immediate S-100B and neuron-specific enlase plasma measurements for rapid evaluation of primary brain damage in alcohol-intoxicated, minor head-injured patients. Shock. 2002; 18: 395-400
|
|
|
|
|
|
36) Iverson GL, Lange RT, Gaetz M, et al. Mild TBI. In: Zasler ND, et al, editors. Brain Injury Medicine. New York: Demos Medical Publishing; 2007. p. 333-71
|
|
|
|
|
|
37) Anderson RE, Hansson LO, Nilsson O, et al. High serum S100B levels for trauma patients without head injuries. Neurosurgery. 2001; 48: 1255-60
|
|
|
|
|
|
38) Stalnacke B-M, Ohlsson A, Tegner Y, et al. Serum concentrations of two biochemical markers of brain tissue damage S-100B and neuron specific enolase are increased in elite female soccer players after a competitive game. Br J Sports Med. 2006; 40: 313-6
|
|
|
|
|
|
39) Kleindienst A, Bullock R. A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. Invited Review. J Neurotrauma. 2006; 23: 1185-200
|
|
|
|
|